{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:50:08Z","timestamp":1761324608343,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:00:00Z","timestamp":1733529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T00:00:00Z","timestamp":1733529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006752","name":"Universidade do Porto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The main objective of this study was to compare laryngeal dystonia (LD) and vocal tremor\u2019s (VT) response to botulinum toxin injection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Retrospective study including every patient with LD or VT injected with botulinum toxin guided by electromyography, from January 1, 2010, to September 30, 2022, at a tertiary hospital centre. Improvement was assessed with the VHI-10, grade of dysphonia in a visual analogue scale (VAS; 0\u201310), GRBAS(I) scale (0\u20133) and maximum phonation time (MPT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 77 patients were included, 44 patients with LD and 33 with VT. There were no differences between groups on pre-treatment VHI-10, grade of dysphonia in the VAS, MPT and G, R, B, A and I at diagnosis (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). S was significantly higher in patients with LD (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). After the first injection, both groups showed an increase in the grade of dysphonia on the VAS and a decrease in VHI-10, G, S and I (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), with a higher variation in the VAS and S parameters in the LD group compared to VT (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). In the 54 patients that performed two or more injections, G, S and I had a higher decrease in patients with LD when compared to patients with VT (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>BTX injection was successful in improving the VHI-10, grade of dysphonia on the VAS and G, S and I in the GRBAS-I scale for both DT and VT. LD seems to have a better response to BTX in comparison to VT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00405-024-09111-z","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T03:18:26Z","timestamp":1733541506000},"page":"919-926","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Laryngeal dystonia and vocal tremor response to botulinum toxin injection"],"prefix":"10.1007","volume":"282","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6485-6786","authenticated-orcid":false,"given":"Jo\u00e3o Viana","family":"Pinto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9177-2070","authenticated-orcid":false,"given":"Isabel Garc\u00eda","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,7]]},"reference":[{"issue":"4","key":"9111_CR1","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1177\/0194599817728521","volume":"157","author":"JM Hintze","year":"2017","unstructured":"Hintze JM, Ludlow CL, Bansberg SF, Adler CH, Lott DG (2017) Spasmodic dysphonia: a review. Part 1: pathogenic factors. Otolaryngol Head Neck Surg 157(4):551\u2013557. https:\/\/doi.org\/10.1177\/0194599817728521","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"21","key":"9111_CR2","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1212\/WNL.0000000000011922","volume":"96","author":"K Simonyan","year":"2021","unstructured":"Simonyan K, Barkmeier-Kraemer J, Blitzer A, Hallett M, Houde JF, Jacobson Kimberley T et al (2021) Laryngeal dystonia: multidisciplinary update on terminology, pathophysiology, and Research priorities. Neurology 96(21):989\u20131001. https:\/\/doi.org\/10.1212\/WNL.0000000000011922","journal-title":"Neurology"},{"key":"9111_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvoice.2023.11.017","author":"JV Pinto","year":"2023","unstructured":"Pinto JV, Perez SS, Garcia-Lopez I (2023) Laryngeal dystonia, Dystonic Tremor and Vocal Tremor: three different entities. J Voice. https:\/\/doi.org\/10.1016\/j.jvoice.2023.11.017","journal-title":"J Voice"},{"issue":"2","key":"9111_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/000348949110000201","volume":"100","author":"A Blitzer","year":"1991","unstructured":"Blitzer A, Brin MF (1991) Laryngeal dystonia: a series with botulinum toxin therapy. Ann Otol Rhinol Laryngol 100(2):85\u201389. https:\/\/doi.org\/10.1177\/000348949110000201","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"2","key":"9111_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1288\/00005537-199202000-00011","volume":"102","author":"A Blitzer","year":"1992","unstructured":"Blitzer A, Brin MF, Stewart C, Aviv JE, Fahn S (1992) Abductor laryngeal dystonia: a series treated with botulinum toxin. Laryngoscope 102(2):163\u2013167. https:\/\/doi.org\/10.1288\/00005537-199202000-00011","journal-title":"Laryngoscope"},{"issue":"8","key":"9111_CR6","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/lary.25273","volume":"125","author":"A Blitzer","year":"2015","unstructured":"Blitzer A, Brin MF, Stewart CF (2015) Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 125(8):1751\u20131757. https:\/\/doi.org\/10.1002\/lary.25273","journal-title":"Laryngoscope"},{"issue":"2","key":"9111_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/000348940611500201","volume":"115","author":"A Chitkara","year":"2006","unstructured":"Chitkara A, Meyer T, Keidar A, Blitzer A (2006) Singer\u2019s dystonia: first report of a variant of spasmodic dysphonia. Ann Otol Rhinol Laryngol 115(2):89\u201392. https:\/\/doi.org\/10.1177\/000348940611500201","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"5","key":"9111_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3810\/pgm.2000.10.1254","volume":"108","author":"CH Adler","year":"2000","unstructured":"Adler CH (2000) Strategies for controlling dystonia. Overview of therapies that may alleviate symptoms. Postgrad Med 108(5):151\u2013152. https:\/\/doi.org\/10.3810\/pgm.2000.10.1254","journal-title":"Postgrad Med"},{"issue":"1","key":"9111_CR9","doi-asserted-by":"publisher","first-page":"e33486","DOI":"10.7759\/cureus.33486","volume":"15","author":"HA Khan","year":"2023","unstructured":"Khan HA (2023) Use of Botulinum Toxin in Spasmodic Dysphonia: a review of recent studies. Cureus 15(1):e33486. https:\/\/doi.org\/10.7759\/cureus.33486","journal-title":"Cureus"},{"key":"9111_CR10","doi-asserted-by":"publisher","unstructured":"Albanese A, Sorbo FD (2016) Dystonia and Tremor: the clinical syndromes with isolated Tremor. Tremor Other Hyperkinet Mov (N Y). 6:319. https:\/\/doi.org\/10.7916\/D8X34XBM","DOI":"10.7916\/D8X34XBM"},{"key":"9111_CR11","unstructured":"Blitzer A, Brin MF, Ramig LO (2011) Neurologic disorders of the Larynx, 2 edn. Thieme"},{"issue":"6","key":"9111_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/MOO.0000000000000412","volume":"25","author":"AL Richards","year":"2017","unstructured":"Richards AL (2017) Vocal tremor: where are we at? Curr Opin Otolaryngol Head Neck Surg 25(6):475\u2013479. https:\/\/doi.org\/10.1097\/MOO.0000000000000412","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"2","key":"9111_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/lio2.544","volume":"6","author":"V Torrecillas","year":"2021","unstructured":"Torrecillas V, Dwenger K, Barkmeier-Kraemer JM (2021) Classification of vocal tremor using updated consensus-based tremor classification criteria. Laryngoscope Investig Otolaryngol 6(2):261\u2013276. https:\/\/doi.org\/10.1002\/lio2.544","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"9111_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvoice.2021.12.009","author":"S Khoury","year":"2022","unstructured":"Khoury S, Randall DR (2022) Treatment of essential vocal tremor: a scoping review of evidence-based therapeutic modalities. J Voice. https:\/\/doi.org\/10.1016\/j.jvoice.2021.12.009","journal-title":"J Voice"},{"issue":"1","key":"9111_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1212\/wnl.35.1.106","volume":"35","author":"W Koller","year":"1985","unstructured":"Koller W, Graner D, Mlcoch A (1985) Essential voice tremor: treatment with propranolol. Neurology 35(1):106\u2013108. https:\/\/doi.org\/10.1212\/wnl.35.1.106","journal-title":"Neurology"},{"key":"9111_CR16","doi-asserted-by":"publisher","unstructured":"Justicz N, Hapner ER, Josephs JS, Boone BC, Jinnah HA, Johns MM 3rd (2016) Comparative effectiveness of propranolol and botulinum for the treatment of essential voice tremor. Laryngoscope 126(1):113\u2013117. https:\/\/doi.org\/10.1002\/lary.25485","DOI":"10.1002\/lary.25485"},{"issue":"9","key":"9111_CR17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0001-6519(07)74954-3","volume":"58","author":"F Nunez-Batalla","year":"2007","unstructured":"Nunez-Batalla F, Corte-Santos P, Senaris-Gonzalez B, Llorente-Pendas JL, Gorriz-Gil C, Suarez-Nieto C (2007) [Adaptation and validation to the Spanish of the Voice Handicap Index (VHI-30) and its shortened version (VHI-10)]. Acta Otorrinolaringol Esp 58(9):386\u2013392","journal-title":"Acta Otorrinolaringol Esp"},{"issue":"10","key":"9111_CR18","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s00405-012-2036-1","volume":"269","author":"GF Volk","year":"2012","unstructured":"Volk GF, Hagen R, Pototschnig C, Friedrich G, Nawka T, Arens C et al (2012) Laryngeal electromyography: a proposal for guidelines of the European Laryngological Society. Eur Arch Otorhinolaryngol 269(10):2227\u20132245. https:\/\/doi.org\/10.1007\/s00405-012-2036-1","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"9111_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1212\/wnl.40.1.66","volume":"40","author":"TG Nygaard","year":"1990","unstructured":"Nygaard TG, Trugman JM, de Yebenes JG, Fahn S (1990) Dopa-responsive dystonia: the spectrum of clinical manifestations in a large north American family. Neurology 40(1):66\u201369. https:\/\/doi.org\/10.1212\/wnl.40.1.66","journal-title":"Neurology"},{"issue":"11","key":"9111_CR20","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/lary.1986.96.11.1300","volume":"96","author":"A Blitzer","year":"1986","unstructured":"Blitzer A, Brin MF, Fahn S, Lange D, Lovelace RE (1986) Botulinum toxin (BOTOX) for the treatment of spastic dysphonia as part of a trial of toxin injections for the treatment of other cranial dystonias. Laryngoscope 96(11):1300\u20131301","journal-title":"Laryngoscope"},{"issue":"2","key":"9111_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/0194599816675320","volume":"156","author":"BF van Esch","year":"2017","unstructured":"van Esch BF, Wegner I, Stegeman I, Grolman W (2017) Effect of Botulinum Toxin and surgery among spasmodic dysphonia patients. Otolaryngol Head Neck Surg 156(2):238\u2013254. https:\/\/doi.org\/10.1177\/0194599816675320","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"9111_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1191\/0269215506cr931oa","volume":"20","author":"C Watts","year":"2006","unstructured":"Watts C, Nye C, Whurr R (2006) Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review. Clin Rehabil 20(2):112\u2013122. https:\/\/doi.org\/10.1191\/0269215506cr931oa","journal-title":"Clin Rehabil"},{"issue":"2","key":"9111_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jvoice.2019.07.025","volume":"35","author":"M Faham","year":"2021","unstructured":"Faham M, Ahmadi A, Silverman E, Harouni GG, Dabirmoghaddam P (2021) Quality of Life after Botulinum Toxin Injection in patients with adductor spasmodic dysphonia; a systematic review and Meta-analysis. J Voice 35(2):271\u2013283. https:\/\/doi.org\/10.1016\/j.jvoice.2019.07.025","journal-title":"J Voice"},{"issue":"1","key":"9111_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/0194599817705612","volume":"157","author":"T Sanuki","year":"2017","unstructured":"Sanuki T, Yumoto E (2017) Long-term evaluation of type 2 Thyroplasty with Titanium bridges for Adductor Spasmodic Dysphonia. Otolaryngol Head Neck Surg 157(1):80\u201384. https:\/\/doi.org\/10.1177\/0194599817705612","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"9111_CR25","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/lary.28105","volume":"130","author":"JHC Schuering","year":"2020","unstructured":"Schuering JHC, Heijnen BJ, Sjogren EV, Langeveld APM (2020) Adductor spasmodic dysphonia: Botulinum toxin a injections or laser thyroarytenoid myoneurectomy? A comparison from the patient perspective. Laryngoscope 130(3):741\u2013746. https:\/\/doi.org\/10.1002\/lary.28105","journal-title":"Laryngoscope"},{"issue":"4","key":"9111_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/01.MLG.0000201990.97955.E4","volume":"116","author":"DK Chhetri","year":"2006","unstructured":"Chhetri DK, Mendelsohn AH, Blumin JH, Berke GS (2006) Long-term follow-up results of selective laryngeal adductor denervation-reinnervation surgery for adductor spasmodic dysphonia. Laryngoscope 116(4):635\u2013642. https:\/\/doi.org\/10.1097\/01.MLG.0000201990.97955.E4","journal-title":"Laryngoscope"},{"key":"9111_CR27","unstructured":"Sataloff RF (2017) Neurolaryngology. 1st ed. Plural Publishing, Inc."},{"key":"9111_CR28","doi-asserted-by":"publisher","first-page":"327928","DOI":"10.1155\/2014\/327928","volume":"2014","author":"JW Kim","year":"2014","unstructured":"Kim JW, Park JH, Park KN, Lee SW (2014) Treatment efficacy of electromyography versus fiberscopy-guided botulinum toxin injection in adductor spasmodic dysphonia patients: a prospective comparative study. ScientificWorldJournal 2014:327928. https:\/\/doi.org\/10.1155\/2014\/327928","journal-title":"ScientificWorldJournal"},{"issue":"9","key":"9111_CR29","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1001\/archneur.61.9.1416","volume":"61","author":"CH Adler","year":"2004","unstructured":"Adler CH, Bansberg SF, Hentz JG, Ramig LO, Buder EH, Witt K et al (2004) Botulinum toxin type A for treating voice tremor. Arch Neurol 61(9):1416\u20131420. https:\/\/doi.org\/10.1001\/archneur.61.9.1416","journal-title":"Arch Neurol"},{"issue":"10","key":"9111_CR30","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1002\/lary.24073","volume":"123","author":"LE Gurey","year":"2013","unstructured":"Gurey LE, Sinclair CF, Blitzer A (2013) A new paradigm for the management of essential vocal tremor with botulinum toxin. Laryngoscope 123(10):2497\u20132501. https:\/\/doi.org\/10.1002\/lary.24073","journal-title":"Laryngoscope"},{"issue":"4","key":"9111_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamaoto.2017.3088","volume":"144","author":"PN Patel","year":"2018","unstructured":"Patel PN, Kabagambe EK, Starkweather JC, Keller M, Gamsarian V, Lee J et al (2018) Outcomes of Onabotulinum Toxin A Treatment for Adductor Spasmodic Dysphonia and Laryngeal Tremor. JAMA Otolaryngol Head Neck Surg 144(4):293\u2013299. https:\/\/doi.org\/10.1001\/jamaoto.2017.3088","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"6","key":"9111_CR32","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/lary.27631","volume":"129","author":"RC Nelson","year":"2019","unstructured":"Nelson RC, Silva Merea V, Tierney WS, Milstein C, Benninger MS, Bryson PC (2019) Laryngeal Botulinum Toxin Injection for Vocal Tremor: utility of concurrent strap muscle injection. Laryngoscope 129(6):1433\u20131437. https:\/\/doi.org\/10.1002\/lary.27631","journal-title":"Laryngoscope"},{"issue":"3","key":"9111_CR33","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jvoice.2018.11.004","volume":"34","author":"M Van Doren","year":"2020","unstructured":"Van Doren M, Faudoa E, Carroll TL (2020) Treatment of patients with vocal fold atrophy and comorbid essential Voice Tremor: long-term injection augmentation outcomes after successful Diagnostic Vocal fold injection augmentation. J Voice 34(3):471\u2013476. https:\/\/doi.org\/10.1016\/j.jvoice.2018.11.004","journal-title":"J Voice"},{"issue":"8","key":"9111_CR34","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1097\/00005537-199908000-00020","volume":"109","author":"GS Berke","year":"1999","unstructured":"Berke GS, Gerratt B, Kreiman J, Jackson K (1999) Treatment of Parkinson hypophonia with percutaneous collagen augmentation. Laryngoscope 109(8):1295\u20131299. https:\/\/doi.org\/10.1097\/00005537-199908000-00020","journal-title":"Laryngoscope"},{"issue":"2","key":"9111_CR35","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/lary.26911","volume":"128","author":"C Estes","year":"2018","unstructured":"Estes C, Sadoughi B, Coleman R, Sarva H, Mauer E, Sulica L (2018) A prospective crossover trial of botulinum toxin chemodenervation versus injection augmentation for essential voice tremor. Laryngoscope 128(2):437\u2013446. https:\/\/doi.org\/10.1002\/lary.26911","journal-title":"Laryngoscope"},{"key":"9111_CR36","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.6061\/clinics\/2018\/e87","volume":"73","author":"G Guglielmino","year":"2018","unstructured":"Guglielmino G, Moraes BT, Villanova LC, Padovani M, Biase NG (2018) Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors. Clin (Sao Paulo) 73:e87. https:\/\/doi.org\/10.6061\/clinics\/2018\/e87","journal-title":"Clin (Sao Paulo)"},{"issue":"1","key":"9111_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jvoice.2013.05.008","volume":"28","author":"DM Orbelo","year":"2014","unstructured":"Orbelo DM, Duffy JR, Hughes Borst BJ, Ekbom D, Maragos NE (2014) Differences in botulinum toxin dosing between patients with adductor spasmodic dysphonia and essential voice tremor. J Voice 28(1):123\u2013127. https:\/\/doi.org\/10.1016\/j.jvoice.2013.05.008","journal-title":"J Voice"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-09111-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-024-09111-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-09111-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T18:46:13Z","timestamp":1738953973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-024-09111-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,7]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["9111"],"URL":"https:\/\/doi.org\/10.1007\/s00405-024-09111-z","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"type":"print","value":"0937-4477"},{"type":"electronic","value":"1434-4726"}],"subject":[],"published":{"date-parts":[[2024,12,7]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}